Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Pfizer

Tracked across 81 events · 1821 articles · First seen Mar 25, 2025 · Last active Sep 24, 2026

Sentiment
11
Attention
8
Events
81
Relationships
34
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 60
Business
Impact: Pfizer India partnered with Cipla to expand the reach of its medicines across India, while continuing to manufacture and supply the four brands involved in the agreement.
Dec 19, 2025 · 6 articles
4 -20
Business
Impact: The departure of its CFO, David Denton, for an opportunity outside the pharmaceutical industry, and the appointment of Cécile Guégan as interim CFO, has led to a slight decrease in Pfizer's stock price.
Jun 18, 2026 · 17 articles
4 65
Tech
Impact: The expanded approval of HYMPAVZI by the United States — Food and Drug Administration>>> is a significant positive development for Pfizer>>>, enhancing its product portfolio and market reach in the hemophilia treatment space. This approval is expected to boost Pfizer>>>'s revenue and solidify its position as a leader in rare disease therapies.
Jun 08, 2026 · 7 articles
2 -10
Business
Impact: Pfizer temporarily discontinued Premarin cream in India due to supply challenges, with no material financial impact expected.
Jul 16, 2026 · 6 articles
3 15
Regulatory
Impact: Pfizer is the applicant seeking FDA approval for its drug combination; positive regulatory news may support revenue growth.
Jul 22, 2026 · 6 articles
4 70
Regulatory
Impact: Pfizer is the lead developer and would exclusively manufacture and commercialize the vaccine if approved. The EMA validation advances its pipeline and could provide a new revenue stream.
Aug 14, 2026 · 12 articles
6 60
Tech
Impact: Pfizer is a pharmaceutical company developing a new Lyme disease vaccine, which has shown 70-75% effectiveness in late-stage studies. The company plans to seek regulatory approval, which could significantly boost its market position in infectious disease prevention.
Apr 30, 2026 · 24 articles
6 70
Tech
Impact: Pfizer manufactures the RSVpreF vaccine, which has shown significant effectiveness in preventing RSV-associated hospitalizations in infants. This positive real-world data validates their product and could lead to increased sales and market share in the vaccine segment.
Jun 05, 2026 · 7 articles
2 -10
Business
On September 7, 2026, Novartis announced the acquisition of the trademarks 'Minipress' and 'Minipres' registered in India, along with related intellectual property rights, from Pfizer and Pfizer — Pfizer Products Inc. for a total consideration…
Impact: Seller of Minipress trademarks and discontinuing manufacture of Minipress XL; receives payment to Pfizer.
Sep 07, 2026 · 6 articles
2 15
International
General Secretary of the Cuba — Communist Party of Cuba Central Committee and President To Lam visited Pfizer in New York on September 22, 2026, as part of his trip to attend the High-Level General…
Impact: Pfizer deepened its partnership with VNVC on vaccine immunisation and disease prevention capacity in Vietnam, reinforcing its emerging-market vaccine business. The cooperation document handover supports its long-term growth in Southeast Asia.
Sep 22, 2026 · 6 articles
4 -30
Regulatory
The India — Karnataka Food Safety and Drugs Administration (FDA) uncovered a large-scale spurious drug racket following an August 18, 2026 raid at a farmhouse in Kurubarakeranahalli, Bidadi, India — Bengaluru South district. Authorities seized…
Impact: Pfizer's brand was counterfeited, leading to suspension of its C&F depot licence and removal of affected batches. The company is cooperating with authorities to protect patient safety and its reputation.
Sep 12, 2026 · 26 articles
4 20
Regulatory
The United States — United States Department of the Treasury is drafting rules governing US pharmaceutical companies' investments in China that would likely preserve their ability to strike most licensing deals for Chinese drugs, according…
Impact: Pfizer has lobbied against broad restrictions and announced an up to $10.5 billion collaboration with Innovent Biologics covering 12 oncology programs.
Sep 18, 2026 · 6 articles
4 50
Business
Impact: Pfizer entered the Chinese market with Xianweiying and partners with gyms for promotions. It is a newer entrant seeking market share.
Aug 24, 2026 · 6 articles
4 75
Regulatory
Impact: Pfizer, a leader in mRNA COVID-19 vaccines, benefits from the broader acceptance of mRNA technology, though the specific flu vaccine approval is not attributed to them.
Aug 06, 2026 · 6 articles
4 75
Tech
Australian researchers from the University of Adelaide and the Ludwig Cancer Research identified a molecular mechanism regulating metastasis in triple-negative breast cancer (TNBC). They found that low levels of miR-342 and high activity of the…
Impact: Manufacturer of palbociclib; positive pre-clinical results could expand its approved indications, increasing revenue potential.
Aug 21, 2026 · 6 articles
6 10
Regulatory
Impact: Pfizer had previously struck a deal with the administration to rein in prices and expects United States — Medicaid discounts to result in price and margin compression next year.
Dec 19, 2025 · 7 articles
2 10
Domestic
Impact: Offers COVID-19 vaccines; benefits from continued recommendations and potential increased uptake.
Sep 02, 2026 · 20 articles
4 20
Tech
Impact: Pfizer, through its Senior Director Neil Patel, provided a positive testimonial for Dataiku Cobuild, indicating potential benefits for the pharmaceutical industry in AI adoption.
Jun 11, 2026 · 6 articles
4 20
Tech
Impact: Pfizer executives are participating in the summit, contributing to discussions on AI adoption and its impact on business cases.
Jun 18, 2026 · 7 articles
3 -20
Domestic
Impact: Pfizer's COVID-19 vaccine (with BioNTech) may see reduced demand in Germany; the company has faced scrutiny over adverse event data.
Jul 13, 2026 · 6 articles
1 10
Business
Impact: Pfizer participated in the symposium, aligning with industry trends toward sustainable pharmaceutical manufacturing.
Jul 20, 2026 · 6 articles
4 60
Tech
Impact: Contributed to the research, potentially gaining early access to a novel therapeutic target for cancer drug development.
Aug 13, 2026 · 6 articles
6 30
Domestic
On August 31, 2026, President Donald Trump announced voluntary drug pricing agreements with nine pharmaceutical companies: Alcon, Astellas Pharma, BeOne Medicines, BridgeBio Pharma, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB. These companies agreed…
Impact: Pfizer was among the earlier 17 drugmakers that signed MFN deals, setting a precedent. The new agreements expand the framework to more companies.
Aug 18, 2026 · 37 articles
4 -5
Tech
AstraZeneca announced on Friday, September 11, 2026, that its breast cancer drug Etcamah (camizestrant) failed to meet the primary endpoint of improving progression-free survival in a late-stage clinical trial. The drug, tested in combination with…
Impact: Pfizer's cancer drug Ibrance was the combination partner in the failed trial, but the negative readout is primarily attributed to AstraZeneca's Etcamah rather than to Ibrance itself.
Sep 11, 2026 · 6 articles
6 60
Tech
Impact: Pfizer has implemented digital manufacturing programs that leverage AI and data-driven systems to improve efficiency and operational performance, demonstrating a broader industry commitment to intelligent manufacturing.
Apr 07, 2026 · 8 articles
6 0
Regulatory
Impact: Pfizer previously signed a deal with the administration regarding drug pricing and co-developed Xtandi with Astellas Pharma.
Apr 20, 2026 · 6 articles
4 30
International
Impact: CEO Albert Bourla joined the AI for Good Global Commission.
Apr 20, 2026 · 123 articles
1 0
Domestic
Impact: Mentioned as vaccine manufacturer; no direct impact from diary release.
Jul 29, 2026 · 13 articles
7 0
Business
Impact: Pfizer is referenced as a historical comparator, having attempted a hostile takeover of AstraZeneca in 2014. The current talks evoke memories of that failed bid.
Aug 02, 2026 · 60 articles
7 -10
Regulatory
Impact: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
+ 51 more events View on Dashboard
ERGEN INTELLIGENCE
Track Pfizer live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.